{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T13:46:26Z","timestamp":1772027186399,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,1,7]],"date-time":"2012-01-07T00:00:00Z","timestamp":1325894400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1007\/s10067-011-1918-8","type":"journal-article","created":{"date-parts":[[2012,1,6]],"date-time":"2012-01-06T13:51:08Z","timestamp":1325857868000},"page":"407-416","source":"Crossref","is-referenced-by-count":9,"title":["The practical value of biologics registries in Africa and Middle East: challenges and opportunities"],"prefix":"10.1007","volume":"31","author":[{"given":"Najia","family":"Hajjaj-Hassouni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marzooq","family":"Al-Badi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ala\u2019","family":"Al-Heresh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samar","family":"Al-Emadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"El Bawendi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayman","family":"El Garf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khaled","family":"El Hadidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hussein","family":"Halabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Hammoudeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selma","family":"El Hassani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Al Maaini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Nahar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A\u00efcha","family":"Ladjouze Rezig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Slaheddine","family":"Sellami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wafaa","family":"Sweiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramiz","family":"Alswailem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beverly","family":"Traub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imad","family":"Uthman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsa","family":"van Duuren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leith","family":"Zakraoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bassel","family":"El Zorkany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loreto","family":"Carmona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxime","family":"Dougados","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,1,7]]},"reference":[{"key":"1918_CR1","unstructured":"The environment and the middle East. Regional and international cooperation, volume 111. Middle East Institute 2011. Available at http:\/\/www.mei.edu\/LinkClick.aspx?fileticket=PHoihEEf1CI%3D&tabid=541 . Accessed 31 July 2011"},{"key":"1918_CR2","unstructured":"The Work of WHO in the Eastern Mediterranean Region: annual report of the regional director, 1 January-31 December 2009. Available at http:\/\/www.emro.who.int\/rd\/annualreports\/2009\/Introduction.htm . Accessed 31 July 2011"},{"key":"1918_CR3","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1136\/bmj.39006.478796.80","volume":"333","author":"W Maziak","year":"2006","unstructured":"Maziak W (2006) Health in the Middle East. BMJ 333:815\u2013816","journal-title":"BMJ"},{"key":"1918_CR4","unstructured":"Achieving sustainable health development in the African region strategic directions for WHO 2010\u20132015. World Health Organization regional office for Africa, Brazzaville, 2010. Available at http:\/\/www.afro.who.int\/index.php?option=com_content&view=article&id=2871:towards-reaching-the-health-related-mdgs&catid=1893&Itemid=2673 . Accessed 31 July 2011"},{"key":"1918_CR5","unstructured":"Symmons D, Mathers C, Pfleger B (2000) The global burden of rheumatoid arthritis in the year 2000. Available at http:\/\/www.who.int\/healthinfo\/statistics\/bod_rheumatoidarthritis.pdf . Accessed 1 August 2011"},{"issue":"6","key":"1918_CR6","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1136\/ard.2009.126532","volume":"69","author":"JS Smolen","year":"2010","unstructured":"Smolen JS, Landew\u00e9 R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C, Gorter S, Knevel R, Nam J, Schoels M, Aletaha D, Buch M, Gossec L, Huizinga T, Bijlsma JW, Burmester G, Combe B, Cutolo M, Gabay C, Gomez-Reino J, Kouloumas M, Kvien TK, Martin-Mola E, McInnes I, Pavelka K, van Riel P, Scholte M, Scott DL, Sokka T, Valesini G, van Vollenhoven R, Winthrop KL, Wong J, Zink A, van der Heijde D (2010) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis 69(6):964\u2013975","journal-title":"Ann Rheum Dis"},{"key":"1918_CR7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.berh.2008.12.009","volume":"23","author":"DL Scott","year":"2009","unstructured":"Scott DL (2009) What have we learnt about the development and progression of early RA from RCTs? Best Pract Res Clin Rheumatol 23:13\u201324","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"Suppl 39","key":"1918_CR8","first-page":"S188","volume":"23","author":"TK Kvien","year":"2005","unstructured":"Kvien TK, Heiberg MS, Lie E, Kaufmann C, Mikkelsen K, Nordv\u00e5g BY, R\u00f8devand E (2005) A Norwegian DMARD register: prescriptions of DMARDs and biological agents to patients with inflammatory rheumatic diseases. Clin Exp Rheumatol 23(Suppl 39):S188\u2013S194","journal-title":"Clin Exp Rheumatol"},{"key":"1918_CR9","doi-asserted-by":"crossref","first-page":"R66","DOI":"10.1186\/ar1933","volume":"8","author":"J Listing","year":"2006","unstructured":"Listing J, Strangfeld A, Rau R, Kekow J, Gromnica-Ihle E, Klopsch T, Demary W, Burmester G, Zink A (2006) Clinical and functional remission: even though biologics are superior to conventional DMARDs overall success rates remain low\u2014results from RABBIT, the German biologics register. Arthritis Res Ther 8:R66","journal-title":"Arthritis Res Ther"},{"key":"1918_CR10","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1136\/ard.2007.072447","volume":"66","author":"W Kievit","year":"2007","unstructured":"Kievit W, Fransen J, Oerlemans AJM, Kuper HH, van der Laar MAFJ, de Rooij DJRAM, De Gendt CMA, Ronday KH, Jansen TL, van Oijen PCM, Brus HLM, Adang EM, van Riel PLCM (2007) The efficacy of anti-TNF in rheumatoid arthritis, a comparison between randomised controlled trials and clinical practice. Ann Rheum Dis 66:1473\u20131478","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"1918_CR11","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1136\/ard.2008.091926","volume":"68","author":"A Zink","year":"2009","unstructured":"Zink A, Askling J, Dixon WG, Klareskog L, Silman AJ, Symmons DP (2009) European biologicals registers: methodology, selected results and perspectives. Ann Rheum Dis 68(8):1240\u20131246","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"1918_CR12","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1136\/ard.2007.085852","volume":"68","author":"J Askling","year":"2009","unstructured":"Askling J, Baecklund E, Granath F, Geborek P, Fored M, Backlin C, Bertilsson L, C\u00f6ster L, Jacobsson LT, Lindblad S, Lysholm J, Rantap\u00e4\u00e4-Dahlqvist S, Saxne T, van Vollenhoven R, Klareskog L, Feltelius N (2009) Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register. Ann Rheum Dis 68(5):648\u2013653","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"1918_CR13","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1136\/ard.2005.045872","volume":"65","author":"J Askling","year":"2006","unstructured":"Askling J, Fored CM, Geborek P, Jacobsson LT, van Vollenhoven R, Feltelius N, Lindblad S, Klareskog L (2006) Swedish registers to examine drug safety and clinical issues in RA. Ann Rheum Dis 65(6):707\u2013712","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"1918_CR14","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/art.11137","volume":"48","author":"JJ G\u00f3mez-Reino","year":"2003","unstructured":"G\u00f3mez-Reino JJ, Carmona L, Valverde VR, Mola EM, Montero MD, BIOBADASER Group (2003) Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report. Arthritis Rheum 48(8):2122\u20132127","journal-title":"Arthritis Rheum"},{"key":"1918_CR15","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/j.1749-6632.2009.04621.x","volume":"1173","author":"A Marchesoni","year":"2009","unstructured":"Marchesoni A, Zaccara E, Gorla R, Bazzani C, Sarzi-Puttini P, Atzeni F, Caporali R, Bobbio-Pallavicini F, Favalli EG (2009) TNF-alpha antagonist survival rate in a cohort of rheumatoid arthritis patients observed under conditions of standard clinical practice. Ann N Y Acad Sci 1173:837\u2013846","journal-title":"Ann N Y Acad Sci"},{"issue":"8","key":"1918_CR16","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/rheumatology\/kem115","volume":"46","author":"A Brennan","year":"2007","unstructured":"Brennan A, Bansback N, Nixon R, Madan J, Harrison M, Watson K, Symmons D (2007) Modelling the cost effectiveness of TNF-alpha antagonists in the management of rheumatoid arthritis: results from the British Society for Rheumatology Biologics Registry. Rheumatology (Oxford) 46(8):1345\u20131354","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"1918_CR17","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/rheumatology\/ken034","volume":"47","author":"JA Karlsson","year":"2008","unstructured":"Karlsson JA, Kristensen LE, Kapetanovic MC, G\u00fclfe A, Saxne T, Geborek P (2008) Treatment response to a second or third TNF-inhibitor in RA: results from the South Swedish Arthritis Treatment Group Register. Rheumatology (Oxford) 47(4):507\u2013513","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"1918_CR18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/art.27227","volume":"62","author":"ML Hetland","year":"2010","unstructured":"Hetland ML, Christensen IJ, Tarp U, Dreyer L, Hansen A, Hansen IT, Kollerup G, Linde L, Lindegaard HM, Poulsen UE, Schlemmer A, Jensen DV, Jensen S, Hostenkamp G, \u00d8stergaard M, All Departments of Rheumatology in Denmark (2010) Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from 8\u00a0years of surveillance of clinical practice in the nationwide Danish DANBIO registry. Arthritis Rheum 62(1):22\u201332","journal-title":"Arthritis Rheum"},{"issue":"9","key":"1918_CR19","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1136\/ard.2009.125526","volume":"69","author":"WG Dixon","year":"2010","unstructured":"Dixon WG, Carmona L, Finckh A, Hetland ML, Kvien TK, Landewe R, Listing J, Nicola PJ, Tarp U, Zink A, Askling J (2010) EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology. Ann Rheum Dis 69(9):1596\u20131602 (Dixon 2010a)","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"1918_CR20","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1002\/art.21978","volume":"54","author":"WG Dixon","year":"2006","unstructured":"Dixon WG, Watson K, Lunt M, Hyrich KL, Silman AJ, Symmons DP, British Society for Rheumatology Biologics Register (2006) Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register. Arthritis Rheum 54(8):2368\u20132376","journal-title":"Arthritis Rheum"},{"issue":"7","key":"1918_CR21","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/rheumatology\/ker146","volume":"50","author":"JB Galloway","year":"2011","unstructured":"Galloway JB, Hyrich KL, Mercer LK, Dixon WG, Watson KD, Lunt M; BSRBR Control Centre Consortium, Symmons DP; on behalf of the British Society for Rheumatology Biologics Register (2011) The risk of serious infections in patients receiving anakinra for rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register. Rheumatology (Oxford) 50 (7):1341\u20131342","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"1918_CR22","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1002\/art.22808","volume":"56","author":"WG Dixon","year":"2007","unstructured":"Dixon WG, Symmons DP, Lunt M, Watson KD, Hyrich KL; British Society for Rheumatology Biologics Register Control Centre Consortium, Silman AJ; British Society for Rheumatology Biologics Register (2007) Serious infection following anti-tumor necrosis factor alpha therapy in patients with rheumatoid arthritis: lessons from interpreting data from observational studies. Arthritis Rheum 56(9):2896\u20132904","journal-title":"Arthritis Rheum"},{"issue":"7","key":"1918_CR23","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1002\/art.24632","volume":"60","author":"F Tubach","year":"2009","unstructured":"Tubach F, Salmon D, Ravaud P, Allanore Y, Goupille P, Br\u00e9ban M, Pallot-Prades B, Pouplin S, Sacchi A, Chichemanian RM, Bretagne S, Emilie D, Lemann M, Lortholary O, Mariette X, Research Axed on Tolerance of Biotherapies Group (2009) Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: the three-year prospective French Research Axed on Tolerance of Biotherapies registry. Arthritis Rheum 60(7):1884\u20131894","journal-title":"Arthritis Rheum"},{"issue":"3","key":"1918_CR24","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/ard.2009.118935","volume":"69","author":"WG Dixon","year":"2010","unstructured":"Dixon WG, Hyrich KL, Watson KD, Lunt M, Galloway J, Ustianowski A; B S R B R Control Centre Consortium, Symmons DP; BSR Biologics Register (2010) Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR). Ann Rheum Dis 69(3):522\u2013528","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"1918_CR25","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/jama.2009.146","volume":"301","author":"A Strangfeld","year":"2009","unstructured":"Strangfeld A, Listing J, Herzer P, Liebhaber A, Rockwitz K, Richter C, Zink A (2009) Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents. JAMA 301(7):737\u2013744","journal-title":"JAMA"},{"issue":"10","key":"1918_CR26","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1136\/ard.2009.125658","volume":"69","author":"I Garc\u00eda-Doval","year":"2010","unstructured":"Garc\u00eda-Doval I, P\u00e9rez-Zafrilla B, Descalzo MA, Rosell\u00f3 R, Hern\u00e1ndez MV, G\u00f3mez-Reino JJ, Carmona L, BIOBADASER 2.0 Study Group (2010) Incidence and risk of hospitalisation due to shingles and chickenpox in patients with rheumatic diseases treated with TNF antagonists. Ann Rheum Dis 69(10):1751\u20131755","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1918_CR27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.autrev.2009.07.006","volume":"9","author":"FB Pallavicini","year":"2010","unstructured":"Pallavicini FB, Caporali R, Sarzi-Puttini P, Atzeni F, Bazzani C, Gorla R, Marchesoni A, Favalli EG, Montecucco C (2010) Tumour necrosis factor antagonist therapy and cancer development: analysis of the LORHEN registry. Autoimmun Rev 9(3):175\u2013180","journal-title":"Autoimmun Rev"},{"issue":"19","key":"1918_CR28","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","volume":"295","author":"T Bongartz","year":"2006","unstructured":"Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V (2006) Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 295(19):2275\u20132285","journal-title":"JAMA"},{"issue":"2","key":"1918_CR29","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/pds.2046","volume":"20","author":"J Askling","year":"2011","unstructured":"Askling J, Fahrbach K, Nordstrom B, Ross S, Schmid CH, Symmons D (2011) Cancer risk with tumor necrosis factor alpha (TNF) inhibitors: meta-analysis of randomized controlled trials of adalimumab, etanercept, and infliximab using patient level data. Pharmacoepidemiol Drug Saf 20(2):119\u2013130","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"1918_CR30","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.semarthrit.2010.08.005","volume":"41","author":"L Carmona","year":"2011","unstructured":"Carmona L, Abasolo L, Descalzo MA, P\u00e9rez-Zafrilla B, Sellas A, de Abajo F, Gomez-Reino JJ, BIOBADASER Study Group; EMECAR Study Group (2011) Cancer in patients with rheumatic diseases exposed to TNF antagonists. Semin Arthritis Rheum 41(1):71\u201380","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"1918_CR31","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/acr.20129","volume":"62","author":"WG Dixon","year":"2010","unstructured":"Dixon WG, Watson KD, Lunt M, Mercer LK, Hyrich KL, Symmons DP, British Society For Rheumatology Biologics Register Control Centre Consortium; British Society for Rheumatology Biologics Register (2010) Influence of anti-tumor necrosis factor therapy on cancer incidence in patients with rheumatoid arthritis who have had a prior malignancy: results from the British Society for Rheumatology Biologics Register. Arthritis Care Res (Hoboken) 62(6):755\u2013763","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"1918_CR32","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1136\/ard.2010.137422","volume":"70","author":"D Salmon-Ceron","year":"2011","unstructured":"Salmon-Ceron D, Tubach F, Lortholary O, Chosidow O, Bretagne S, Nicolas N, Cuillerier E, Fautrel B, Michelet C, Morel J, Pu\u00e9chal X, Wendling D, Lemann M, Ravaud P, Mariette X, RATIO group (2011) Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry. Ann Rheum Dis 70(4):616\u2013623","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"1918_CR33","doi-asserted-by":"crossref","first-page":"928","DOI":"10.3899\/jrheum.091107","volume":"37","author":"S Bernatsky","year":"2010","unstructured":"Bernatsky S, Habel Y, Rahme E (2010) Observational studies of infections in rheumatoid arthritis: a metaanalysis of tumor necrosis factor antagonists. J Rheumatol 37(5):928\u2013931","journal-title":"J Rheumatol"},{"issue":"suppl 10","key":"1918_CR34","first-page":"1841","volume":"62","author":"LM Ornbjerg","year":"2010","unstructured":"Ornbjerg LM, Ostergaard MB, Boyesen M, Thormann P, Tarp A, Bohme U, Dencker WD (2010) Treatment with TNF inhibitors reduces radiographic joint destruction in rheumatoid arthritis patients treated in clinical practice. Arthritis Rheum 62(suppl 10):1841","journal-title":"Arthritis Rheum"},{"issue":"suppl 10","key":"1918_CR35","first-page":"377","volume":"62","author":"EU Lie","year":"2010","unstructured":"Lie EU, Mikkelsen T, Kalstaa K, Rodevand S, Kaufmann E, Kvien C, Tore K (2010) Better results are achieved by switching directly to biologics than switching via DMARD combinations in RA patients who have failed methotrexate as their initial DMARD: real life data from NOR-DMARD. Arthritis Rheum 62(suppl 10):377","journal-title":"Arthritis Rheum"},{"issue":"12","key":"1918_CR36","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1136\/ard.2008.098467","volume":"68","author":"A Strangfeld","year":"2009","unstructured":"Strangfeld A, Hierse F, Kekow J, von Hinueber U, Tony HP, Dockhorn R, Listing J, Zink A (2009) Comparative effectiveness of tumour necrosis factor alpha inhibitors in combination with either methotrexate or leflunomide. Ann Rheum Dis 68(12):1856\u20131862","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"1918_CR37","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1136\/ard.2006.067660","volume":"66","author":"L Carmona","year":"2007","unstructured":"Carmona L, Descalzo MA, Perez-Pampin E, Ruiz-Montesinos D, Erra A, Cobo T, G\u00f3mez-Reino JJ, BIOBADASER and EMECAR Groups (2007) All-cause and cause-specific mortality in rheumatoid arthritis are not greater than expected when treated with tumour necrosis factor antagonists. Ann Rheum Dis 66(7):880\u2013885","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"1918_CR38","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1002\/art.22809","volume":"56","author":"WG Dixon","year":"2007","unstructured":"Dixon WG, Watson KD, Lunt M, Hyrich KL; British Society for Rheumatology Biologics Register Control Centre Consortium, Silman AJ, Symmons DP; British Society for Rheumatology Biologics Register (2007) Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register. Arthritis Rheum 56(9):2905\u20132912","journal-title":"Arthritis Rheum"},{"issue":"5","key":"1918_CR39","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1136\/ard.2006.062497","volume":"66","author":"LT Jacobsson","year":"2007","unstructured":"Jacobsson LT, Turesson C, Nilsson JA, Petersson IF, Lindqvist E, Saxne T, Geborek P (2007) Treatment with TNF blockers and mortality risk in patients with rheumatoid arthritis. Ann Rheum Dis 66(5):670\u2013675","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"1918_CR40","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s10067-007-0782-z","volume":"27","author":"H Badsha","year":"2008","unstructured":"Badsha H, Kong KO, Tak PP (2008) Rheumatoid arthritis in the United Arab Emirates. Clin Rheumatol 27(6):739\u2013742","journal-title":"Clin Rheumatol"},{"key":"1918_CR41","unstructured":"Global tuberculosis control. World Health Organization Report 2010. Available at http:\/\/www.who.int\/tb\/publications\/global_report\/2010\/en\/index.html . Accessed 3 August 2011"},{"key":"1918_CR42","unstructured":"World Health Organization, Regional Committee for the Eastern Mediterranean, The growing threats of hepatitis B and C in the Eastern Mediterranean Region: a call for action. Available at http:\/\/www.emro.who.int\/rc56\/media\/pdf\/emrc56r5.pdf . Accessed on 10 July 2011"},{"key":"1918_CR43","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1111\/j.1872-034X.2007.00098.x","volume":"37","author":"A Kramvis","year":"2007","unstructured":"Kramvis A, Kew MC (2007) Epidemiology of hepatitis B virus and its genotypes in Africa, and the clinical associations of the genotypes. Hepatol Res 37:S9\u2013S19, Abstract","journal-title":"Hepatol Res"},{"issue":"5","key":"1918_CR44","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S1473-3099(02)00264-5","volume":"2","author":"V Madhava","year":"2002","unstructured":"Madhava V, Burgess C, Drucker E (2002) Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa. Lancet Infect Dis 2(5):293\u2013302","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"1918_CR45","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/ibd.21336","volume":"17","author":"CS Coffin","year":"2011","unstructured":"Coffin CS, Fraser HF, Panaccione R, Ghosh S (2011) Liver diseases associated with anti-tumor necrosis factor-alpha (TNF-\u03b1) use for inflammatory bowel disease. Inflamm Bowel Dis 17(1):479\u2013484","journal-title":"Inflamm Bowel Dis"},{"key":"1918_CR46","unstructured":"World Health Organization. Regional Office for the Eastern Mediterranean Region. Cardiovascular diseases. Available at http:\/\/www.emro.who.int\/ncd\/cardiovascular_diseases.htm . Accessed on 10 July 2011"},{"key":"1918_CR47","unstructured":"World Health Organization 2011, Media Centre, Cardiovascular Diseases, Fact Sheets. Available at http:\/\/www.who.int\/mediacentre\/factsheets\/fs317\/en\/index.html . Accessed on 10 July 2011"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-011-1918-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-011-1918-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-011-1918-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:51:53Z","timestamp":1559119913000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-011-1918-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,7]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["1918"],"URL":"https:\/\/doi.org\/10.1007\/s10067-011-1918-8","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,7]]}}}